These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38423377)

  • 1. Both HFpEF and HFmrEF should be included in calculating CHA
    Cheng CC; Huang PS; Chen JJ; Chiu FC; Chang SN; Wang YC; Wu CK; Hwang JJ; Tsai CT
    Heart Rhythm; 2024 Sep; 21(9):1500-1506. PubMed ID: 38423377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Sartipy U; Dahlström U; Fu M; Lund LH
    JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation and risk of adverse outcomes in heart failure with reduced, mildly reduced, and preserved ejection fraction: A systematic review and meta-analysis.
    Kroshian G; Joseph J; Kinlay S; Peralta AO; Hoffmeister PS; Singh JP; Yuyun MF
    J Cardiovasc Electrophysiol; 2024 Apr; 35(4):715-726. PubMed ID: 38348517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and effectiveness of left atrial appendage closure in atrial fibrillation patients with different types of heart failure.
    Liu L; Yan W; Xu X; Wan C; Liu F; Yao Q; Song L; Wang B; Song Z; Li H
    BMC Cardiovasc Disord; 2024 Aug; 24(1):430. PubMed ID: 39148039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
    Son MK; Park JJ; Lim NK; Kim WH; Choi DJ
    Heart; 2020 Aug; 106(15):1160-1168. PubMed ID: 32341140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review and meta-analysis of stroke and thromboembolism risk in atrial fibrillation with preserved vs. reduced ejection fraction heart failure.
    Zhang M; Zhou J
    BMC Cardiovasc Disord; 2024 Sep; 24(1):495. PubMed ID: 39289613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF).
    Sobue Y; Watanabe E; Lip GYH; Koshikawa M; Ichikawa T; Kawai M; Harada M; Inamasu J; Ozaki Y
    Heart Vessels; 2018 Apr; 33(4):403-412. PubMed ID: 29067492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke and Systemic Embolism and Other Adverse Outcomes of Heart Failure With Preserved and Reduced Ejection Fraction in Patients With Atrial Fibrillation (from the COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation [CODE-AF]).
    Chung S; Kim TH; Uhm JS; Cha MJ; Lee JM; Park J; Park JK; Kang KW; Kim J; Park HW; Choi EK; Kim JB; Kim CS; Lee YS; Shim J; Joung B
    Am J Cardiol; 2020 Jan; 125(1):68-75. PubMed ID: 31699363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stroke and systemic embolism in patients with atrial fibrillation and heart failure according to heart failure type.
    Uhm JS; Kim J; Yu HT; Kim TH; Lee SR; Cha MJ; Choi EK; Lee JM; Kim JB; Park J; Park JK; Kang KW; Shim J; Park HW; Lee YS; Kim CS; Mun JE; Son NH; Joung B
    ESC Heart Fail; 2021 Apr; 8(2):1582-1589. PubMed ID: 33634593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for predicting incident atrial fibrillation in heart failure with preserved ejection fraction patients.
    Wu Y; Xie Z; Liang W; Xue R; Wu Z; Wu D; He J; Zhu W; Liu C
    ESC Heart Fail; 2021 Apr; 8(2):1369-1377. PubMed ID: 33506643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive population-based characterization of heart failure with mid-range ejection fraction.
    Koh AS; Tay WT; Teng THK; Vedin O; Benson L; Dahlstrom U; Savarese G; Lam CSP; Lund LH
    Eur J Heart Fail; 2017 Dec; 19(12):1624-1634. PubMed ID: 28948683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Atrial Fibrillation Ablation in Heart Failure Subtypes.
    Younis A; Tabaja C; Santangeli P; Nakagawa H; Sipko J; Madden R; Bouscher P; Taigen T; Higuchi K; Hayashi K; El Hajjar AH; Chamseddine F; Callahan T; Martin DO; Nakhla S; Kanj M; Sroubek J; Lee JZ; Saliba WI; Wazni OM; Hussein AA
    Circ Arrhythm Electrophysiol; 2024 Sep; 17(9):e012926. PubMed ID: 39193716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post-hoc analysis of the ATHENA trial.
    Vaduganathan M; Piccini JP; Camm AJ; Crijns HJGM; Anker SD; Butler J; Stewart J; Braceras R; Albuquerque APA; Wieloch M; Hohnloser SH
    Eur J Heart Fail; 2022 Jun; 24(6):1094-1101. PubMed ID: 35293087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis and treatment strategies for atrial fibrillation in heart failure with mildly reduced ejection fraction.
    Schupp T; Schmitt A; Reinhardt M; Abel N; Lau F; Abumayyaleh M; Dudda J; Weidner K; Ayoub M; Akin M; Müller J; Akin I; Behnes M
    Eur J Prev Cardiol; 2024 Aug; 31(11):1372-1384. PubMed ID: 38825871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild and moderate to severe early acute kidney injury following cardiac surgery among patients with heart failure and preserved vs. mid-range vs. reduced ejection fraction: A retrospective cohort study.
    Gao Y; Wang C; Li J; Ji B; Wang J; Yan F; Wang Y
    Eur J Anaesthesiol; 2022 Aug; 39(8):673-684. PubMed ID: 35791895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry.
    Zafrir B; Lund LH; Laroche C; Ruschitzka F; Crespo-Leiro MG; Coats AJS; Anker SD; Filippatos G; Seferovic PM; Maggioni AP; De Mora Martin M; Polonski L; Silva-Cardoso J; Amir O;
    Eur Heart J; 2018 Dec; 39(48):4277-4284. PubMed ID: 30325423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation in patients with atrial fibrillation and heart failure: Insights from the NCDR PINNACLE-AF registry.
    Contreras JP; Hong KN; Castillo J; Marzec LN; Hsu JC; Cannon CP; Yang S; Maddox TM
    Clin Cardiol; 2019 Mar; 42(3):339-345. PubMed ID: 30582177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of atrial fibrillation on rest and exercise haemodynamics in heart failure with mid-range and preserved ejection fraction.
    Kaye DM; Silvestry FE; Gustafsson F; Cleland JG; van Veldhuisen DJ; Ponikowski P; Komtebedde J; Nanayakkara S; Burkhoff D; Shah SJ
    Eur J Heart Fail; 2017 Dec; 19(12):1690-1697. PubMed ID: 29024227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction.
    Abdul-Rahim AH; Shen L; Rush CJ; Jhund PS; Lees KR; McMurray JJV;
    Eur J Heart Fail; 2018 Jul; 20(7):1139-1145. PubMed ID: 29493058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors and outcomes of heart failure with mid-range ejection fraction.
    Bhambhani V; Kizer JR; Lima JAC; van der Harst P; Bahrami H; Nayor M; de Filippi CR; Enserro D; Blaha MJ; Cushman M; Wang TJ; Gansevoort RT; Fox CS; Gaggin HK; Kop WJ; Liu K; Vasan RS; Psaty BM; Lee DS; Brouwers FP; Hillege HL; Bartz TM; Benjamin EJ; Chan C; Allison M; Gardin JM; Januzzi JL; Levy D; Herrington DM; van Gilst WH; Bertoni AG; Larson MG; de Boer RA; Gottdiener JS; Shah SJ; Ho JE
    Eur J Heart Fail; 2018 Apr; 20(4):651-659. PubMed ID: 29226491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.